NCM
KRRO icon

Nantahala Capital Management’s Korro Bio KRRO Stock Holding History

Nantahala Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.47M Buy
660,036
+60,036
+10% +$661K 0.28% 82
2025
Q4 		$4.81M Buy
+600,000
New +$14M 0.16% 101

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Nantahala Capital Management's KRRO Position: Q1 2026 in Review

Nantahala Capital Management increased its Korro Bio (KRRO) stake by 10% in Q1 2026, buying an estimated $661K and bringing the position to 660,036 shares worth $7.47M. The position accounts for 0.28% of the portfolio, ranked #82.

Nantahala Capital Management first reported a position in KRRO in Q4 2025 and has held it in 2 quarters since. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Nantahala Capital Management held 660,036 shares of Korro Bio worth $7.47M as of Q1 2026.
  • Nantahala Capital Management bought 60,036 Korro Bio shares in Q1 2026, an estimated $661K.
  • Korro Bio made up 0.28% of Nantahala Capital Management's portfolio in Q1 2026, its #82 holding.
  • Nantahala Capital Management first reported a position in Korro Bio in Q4 2025 and has held it in 2 quarters since.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.